Bile duct device study pulled before it began
NCT ID NCT06666699
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study was designed to test a new device for accessing the bile duct in patients with bile duct blockages caused by cancer. The goal was to see if the device could safely and effectively help drain the bile. However, the study was withdrawn before any patients were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EUS access device
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT BILIARY OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asian Institute of Gastroenterology
Hyderabad, Telangana, 500032, India
-
Georges Pompidou European Hospital
Paris, 75015, France
-
Ghent University Hospital
Ghent, 9000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Draining the bile duct: does it improve daily life for cancer patients?
- New stent study aims to ease bile duct blockage in pancreatic cancer patients
- New study tests safer bile duct drainage for cancer patients
- New study compares two drainage techniques to ease jaundice in advanced cancer patients
- Which stent is best for unblocking bile ducts in cancer patients?
- New stent technique may lower infection risk in bile duct cancer patients